These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30071057)

  • 1. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.
    Oshima M; Toyama T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Hara A; Makino H; Wada T;
    PLoS One; 2018; 13(8):e0201535. PubMed ID: 30071057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
    Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate.
    Matsushita K; Chen J; Sang Y; Ballew SH; Shimazaki R; Fukagawa M; Imai E; Coresh J; Hishida A
    Kidney Int; 2016 Nov; 90(5):1109-1114. PubMed ID: 27666758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
    Kanda E; Usui T; Kashihara N; Iseki C; Iseki K; Nangaku M
    Clin Exp Nephrol; 2018 Apr; 22(2):318-327. PubMed ID: 28884361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
    Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP).
    Chang TI; Li S; Chen SC; Peralta CA; Shlipak MG; Fried LF; Whaley-Connell AT; McCullough PA; Kurella Tamura M;
    Am J Kidney Dis; 2013 Apr; 61(4 Suppl 2):S4-11. PubMed ID: 23507268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.
    Coresh J; Turin TC; Matsushita K; Sang Y; Ballew SH; Appel LJ; Arima H; Chadban SJ; Cirillo M; Djurdjev O; Green JA; Heine GH; Inker LA; Irie F; Ishani A; Ix JH; Kovesdy CP; Marks A; Ohkubo T; Shalev V; Shankar A; Wen CP; de Jong PE; Iseki K; Stengel B; Gansevoort RT; Levey AS
    JAMA; 2014 Jun; 311(24):2518-2531. PubMed ID: 24892770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in novel filtration markers and risk of ESRD.
    Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of ESRD and Mortality Associated With Change in Filtration Markers.
    Rebholz CM; Inker LA; Chen Y; Liang M; Foster MC; Eckfeldt JH; Kimmel PL; Vasan RS; Feldman HI; Sarnak MJ; Hsu CY; Levey AS; Coresh J;
    Am J Kidney Dis; 2017 Oct; 70(4):551-560. PubMed ID: 28648303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Jiang G; Luk AOY; Tam CHT; Xie F; Carstensen B; Lau ESH; Lim CKP; Lee HM; Ng ACW; Ng MCY; Ozaki R; Kong APS; Chow CC; Yang X; Lan HY; Tsui SKW; Fan X; Szeto CC; So WY; Chan JCN; Ma RCW;
    Kidney Int; 2019 Jan; 95(1):178-187. PubMed ID: 30415941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of sex on renal function decline in people with Type 2 diabetes.
    de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
    Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
    Heerspink HJ; Persson F; Brenner BM; Chaturvedi N; Brunel P; McMurray JJ; Desai AS; Solomon SD; Pfeffer MA; Parving HH; de Zeeuw D
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):309-17. PubMed ID: 26774608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).
    Lambers Heerspink HJ; Weldegiorgis M; Inker LA; Gansevoort R; Parving HH; Dwyer JP; Mondal H; Coresh J; Greene T; Levey AS; de Zeeuw D
    Am J Kidney Dis; 2014 Feb; 63(2):244-50. PubMed ID: 24210590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin genotype and renal function decline in type 1 diabetes.
    Costacou T; Ferrell RE; Ellis D; Orchard TJ
    Diabetes; 2009 Dec; 58(12):2904-9. PubMed ID: 19720796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes.
    Skupien J; Warram JH; Smiles AM; Stanton RC; Krolewski AS
    Diabetes Care; 2016 Dec; 39(12):2262-2269. PubMed ID: 27647852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and the Subsequent Risk of End-Stage Renal Disease - Usefulness of 30% Decline in Estimated GFR over 2 Years.
    Chang WX; Asakawa S; Toyoki D; Nemoto Y; Morimoto C; Tamura Y; Ota T; Shibata S; Fujigaki Y; Shen ZY; Uchida S
    PLoS One; 2015; 10(7):e0132927. PubMed ID: 26177463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
    Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
    J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.